Blood test for predicting sepsis death in kids steps closer to reality
November 14, 2019 -- Rapid blood test results for five biomarkers correlated with sepsis outcomes in a study of children treated in intensive care units, which suggests potential for use as a predictive test for risk of death. The findings were published online November 13 in Science Translational Medicine.  Discuss
Becton Dickinson files for Onclarity FDA approval in 11 more HPV types
November 14, 2019 -- Becton Dickinson has submitted a premarket approval filing with the U.S. Food and Drug Administration (FDA) for its Onclarity test for an expanded number of HPV genotypes.
Inflammatix scores BARDA contract for infection tests
November 14, 2019 -- Startup Inflammatix is set to get $6 million from the U.S. Biomedical Advanced Research and Development Authority (BARDA) and up to $72 million as part of a cost-sharing contract to develop its rapid point-of-care tests for infections.
Hologic airs validating data for Aptima STI test
November 12, 2019 -- A study demonstrating the effectiveness of Hologic's Aptima assay for the increasingly common sexually transmitted infection (STI) Mycoplasma genitalium has been published in the Journal of Clinical Microbiology.
AMP highlights: Products aim to beat the clock in cancer detection
November 11, 2019 -- Cancer was a key focus at the recent Association for Molecular Pathology (AMP) annual meeting in Baltimore -- particularly faster detection and treatment selection, according to Bruce Carlson, publisher of Kalorama Information.  Discuss
AMP roundup: Vendors showcase same-day NGS, faster prep, DNA/RNA combos
November 7, 2019 -- BALTIMORE - Bruce Carlson, publisher of Kalorama Information, is on the ground at the Baltimore Convention Center for this week's Association for Molecular Pathology (AMP) meeting, reporting on product introductions.  Discuss
Thermo Fisher teams with Owlstone on breath tests
November 7, 2019 -- Thermo Fisher Scientific is working with Owlstone Medical to develop noninvasive breath sample tests in a collaboration that will include the discovery and validation of new biomarkers for the earlier detection of disease.
AMP lineup shows changing of the guard in molecular tech
November 6, 2019 -- Bruce Carlson, publisher of Kalorama Information, shares his thoughts on the many vendor workshops slated for the upcoming Association for Molecular Pathology (AMP) annual meeting in Baltimore.  Discuss
Vela wins FDA clearance for HIV-1 genotyping NGS assay
November 6, 2019 -- Vela Diagnostics USA has garnered U.S. Food and Drug Administration (FDA) marketing approval for its Sentosa SQ HIV-1 genotyping assay, a test designed to detect HIV-1 drug resistance mutations using next-generation sequencing (NGS) technology.
Qiagen TB blood test headed for wider global use
October 31, 2019 -- Qiagen's Quantiferon-TB Gold Plus blood test for detecting latent tuberculosis (TB) made the list of diagnostics in the international Stop TB Partnership Global Drug Facility product catalog.